Sinocare Inc.
SZSE:300298.SZ
28.21 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 4,058.786 | 2,813.501 | 2,361.308 | 2,015.214 | 1,778.209 | 1,550.513 | 1,033.008 | 795.841 | 645.501 | 544.923 | 449.053 | 339.121 | 209.474 | 160.231 | 69.531 | 35.304 |
Cost of Revenue
| 1,888.333 | 1,161.833 | 945.347 | 700.219 | 619.913 | 560.981 | 335.791 | 285.895 | 220.989 | 169.454 | 147.314 | 100.644 | 62.672 | 57.589 | 22.793 | 19.178 |
Gross Profit
| 2,170.453 | 1,651.668 | 1,415.961 | 1,314.995 | 1,158.296 | 989.533 | 697.216 | 509.946 | 424.511 | 375.469 | 301.74 | 238.477 | 146.802 | 102.642 | 46.738 | 16.126 |
Gross Profit Ratio
| 0.535 | 0.587 | 0.6 | 0.653 | 0.651 | 0.638 | 0.675 | 0.641 | 0.658 | 0.689 | 0.672 | 0.703 | 0.701 | 0.641 | 0.672 | 0.457 |
Reseach & Development Expenses
| 356.405 | 259.833 | 182.434 | 182.49 | 161.335 | 128.819 | 73.981 | 51.983 | 38.963 | 27.862 | 21.039 | 11.072 | 6.904 | 6.554 | 4.474 | 0 |
General & Administrative Expenses
| 137.481 | 50.614 | 41.667 | 61.72 | 47.258 | 41.708 | 25.105 | 25.557 | 23.893 | 6.902 | 6.984 | 11.225 | 3.023 | 2.481 | 1.919 | 4.432 |
Selling & Marketing Expenses
| 1,001.481 | 751.325 | 724.624 | 584.352 | 488.903 | 451.775 | 290.287 | 246.909 | 219.705 | 131.378 | 110.252 | 89.334 | 34.542 | 31.414 | 13.661 | 6.443 |
SG&A
| 1,138.962 | 801.939 | 766.291 | 646.072 | 536.161 | 493.483 | 315.392 | 272.466 | 243.598 | 138.281 | 117.236 | 100.559 | 37.565 | 33.894 | 15.58 | 10.876 |
Other Expenses
| 107.701 | 114.686 | 97.857 | 59.13 | 57.76 | 9.345 | 7.708 | 63.547 | 23.656 | 32.166 | 21.496 | 10.342 | 3.592 | 4.671 | 5.139 | 2.917 |
Operating Expenses
| 1,734.581 | 1,176.458 | 1,046.582 | 887.692 | 755.256 | 653.085 | 398.073 | 355.012 | 310.791 | 199.452 | 154.945 | 121.33 | 50.979 | 45.227 | 23.302 | 11.196 |
Operating Income
| 275.011 | 470.212 | 285.216 | 370.923 | 373.54 | 344.868 | 297.426 | 73.152 | 138.027 | 198.032 | 169.298 | 139.639 | 99.323 | 58.517 | 23.621 | 4.631 |
Operating Income Ratio
| 0.068 | 0.167 | 0.121 | 0.184 | 0.21 | 0.222 | 0.288 | 0.092 | 0.214 | 0.363 | 0.377 | 0.412 | 0.474 | 0.365 | 0.34 | 0.131 |
Total Other Income Expenses Net
| -26.45 | 69.362 | -147.038 | -123.147 | -72.082 | 9.345 | 7.708 | 63.547 | 23.656 | 32.166 | 21.496 | 10.03 | 7.006 | 5.9 | 5.139 | 2.917 |
Income Before Tax
| 248.561 | 469.992 | 138.177 | 247.775 | 301.458 | 354.213 | 305.133 | 136.32 | 161.683 | 230.197 | 190.794 | 149.669 | 102.915 | 63.188 | 28.76 | 7.548 |
Income Before Tax Ratio
| 0.061 | 0.167 | 0.059 | 0.123 | 0.17 | 0.228 | 0.295 | 0.171 | 0.25 | 0.422 | 0.425 | 0.441 | 0.491 | 0.394 | 0.414 | 0.214 |
Income Tax Expense
| 52.716 | 42.036 | 31.163 | 60.885 | 50.774 | 43.765 | 47.188 | 21.825 | 18.569 | 32.858 | 25.488 | 20.843 | 14.754 | 8.329 | 2.686 | 0.38 |
Net Income
| 284.398 | 446.507 | 107.569 | 186.89 | 250.683 | 310.448 | 257.972 | 115.198 | 143.663 | 197.339 | 165.306 | 128.826 | 88.161 | 54.859 | 26.074 | 7.168 |
Net Income Ratio
| 0.07 | 0.159 | 0.046 | 0.093 | 0.141 | 0.2 | 0.25 | 0.145 | 0.223 | 0.362 | 0.368 | 0.38 | 0.421 | 0.342 | 0.375 | 0.203 |
EPS
| 0.51 | 0.77 | 0.19 | 0.34 | 0.45 | 0.56 | 0.53 | 0.24 | 0.38 | 0.53 | 0.34 | 0.43 | 0.24 | 0.17 | 0.079 | 0.26 |
EPS Diluted
| 0.51 | 0.77 | 0.19 | 0.34 | 0.45 | 0.56 | 0.53 | 0.24 | 0.38 | 0.53 | 0.34 | 0.43 | 0.24 | 0.17 | 0.079 | 0.26 |
EBITDA
| 537.129 | 799.469 | 270.746 | 342.511 | 399.448 | 426.789 | 330.911 | 176.656 | 128.54 | 181.323 | 150.337 | 119.819 | 105.186 | 58.875 | 24.483 | 5.36 |
EBITDA Ratio
| 0.128 | 0.227 | 0.165 | 0.251 | 0.248 | 0.274 | 0.326 | 0.229 | 0.201 | 0.345 | 0.339 | 0.356 | 0.466 | 0.368 | 0.351 | 0.165 |